#None #Class Action #Securities Fraud #Inspire Medical

Levi & Korsinsky Alerts Inspire Medical Systems Investors About Class Action

In the latest developments on December 12, 2025, law firm Levi & Korsinsky, LLP has notified investors of Inspire Medical Systems, Inc. regarding a class action securities lawsuit which raises serious allegations against the company's practices. The lawsuit aims to recover losses sustained by investors who were adversely impacted by alleged securities fraud occurring between August 6, 2024, and August 4, 2025.

Details of the Case

The class action lawsuit is centered around claims that Inspire Medical Systems misled investors about the launch of its new product, Inspire V. Reports indicate that the launch was not as successful as initially represented, with a notable lack of demand and excess inventory at treatment centers. Furthermore, the lawsuit contends that essential preparations for the launch were inadequately addressed. According to the complaint, the defendants failed to fulfill critical tasks such as:

• - Completing necessary training and onboarding for treatment center clients.
• - Establishing basic IT systems, which included a customer approval process.
• - Updating vital claims management software to ensure efficient claims processing and compensation.
• - Securing Medicare reimbursement prior to the product launch, which could affect billing for services rendered with the new device.

These oversights were in stark contradiction with the company's previous assurances, which claimed that the launch preparations were thoroughly and successfully implemented. The lawsuit seeks restitution for the investors who were misled during this time frame.

Next Steps for Investors

For those who have experienced financial losses due to their investments in Inspire Medical Systems during the specified period, January 5, 2026, marks a crucial deadline. It is the last day to request the court to appoint them as lead plaintiffs in this lawsuit. However, it is significant to note that participating in any potential recovery does not necessitate serving as a lead plaintiff.

This class action poses no financial risk to eligible members; there are no out-of-pocket costs or fees for those who wish to take part. Levi & Korsinsky assures investors that compensation might be available to them as part of this legal action without any financial obligation initially incurred.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has accumulated over two decades of experience in securities litigation and has garnered substantial recoveries for shareholders. Their track record includes a ranking in the top 50 firms for securities litigation by ISS Securities Class Action Services for seven consecutive years. Their dedicated team comprises over 70 professionals skilled in navigating complex legalities and representing investors’ interests effectively.

To reach out for further inquiries or for submission to join the lawsuit, investors can contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

Conclusion

Investors in Inspire Medical Systems should remain informed about the ongoing class action lawsuit, particularly regarding their rights and potential avenues for compensation. As the industry observes this case closely, it underscores the importance of transparency and due diligence in the medical devices sector, where investors rely heavily on accurate information about product launches and company performances.